BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 38211367)

  • 1. Effectiveness of residential treatment services for veterans with substance use disorders: A propensity score matching evaluation.
    Dams GM; Ketchen BR; Burden JL; Smith NB
    Drug Alcohol Depend; 2024 Feb; 255():111081. PubMed ID: 38211367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of implementing a tobacco and recreational nicotine-free policy and enhanced treatments on programmatic and patient-level outcomes within a residential substance use disorder treatment program.
    Hemmy Asamsama O; Miller SC; Silvestri MM; Bonanno C; Krondilou K
    J Subst Abuse Treat; 2019 Dec; 107():44-49. PubMed ID: 31757264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. VA residential substance use disorder treatment program providers' perceptions of facilitators and barriers to performance on pre-admission processes.
    Ellerbe LS; Manfredi L; Gupta S; Phelps TE; Bowe TR; Rubinsky AD; Burden JL; Harris AH
    Addict Sci Clin Pract; 2017 Apr; 12(1):10. PubMed ID: 28372579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Individualized Addictions Consultation Team Residential Program: A Creative Solution for Integrating Care for Veterans With Substance Use Disorders Too Complex for Other Residential Treatment Programs.
    Keating S; Larsen SE; Collingwood J; Smith HM
    J Dual Diagn; 2021; 17(2):172-179. PubMed ID: 33583351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gender differences in service utilization among Operations Enduring Freedom, Iraqi Freedom, and New Dawn Veterans Affairs patients with severe mental illness and substance use disorders.
    Painter JM; Brignone E; Gilmore AK; Lehavot K; Fargo J; Suo Y; Simpson T; Carter ME; Blais RK; Gundlapalli AV
    Psychol Serv; 2018 Feb; 15(1):11-20. PubMed ID: 28517950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrating comprehensive hepatitis C virus care within a residential substance use disorder treatment program.
    Burton MJ; Voluse AC; Anthony V
    J Subst Abuse Treat; 2019 Mar; 98():9-14. PubMed ID: 30665610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High inpatient utilization among Veterans Health Administration patients with substance-use disorders and co-occurring mental health conditions.
    Painter JM; Malte CA; Rubinsky AD; Campellone TR; Gilmore AK; Baer JS; Hawkins EJ
    Am J Drug Alcohol Abuse; 2018; 44(3):386-394. PubMed ID: 29095057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive validity of two process-of-care quality measures for residential substance use disorder treatment.
    Harris AH; Gupta S; Bowe T; Ellerbe LS; Phelps TE; Rubinsky AD; Finney JW; Asch SM; Humphreys K; Trafton J
    Addict Sci Clin Pract; 2015 Oct; 10():22. PubMed ID: 26520402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outpatient continuing care after residential substance use disorder treatment in the US Veterans Health Administration: Facilitators and challenges.
    Rubinsky AD; Ellerbe LS; Gupta S; Phelps TE; Bowe T; Burden JL; Harris AHS
    Subst Abus; 2018; 39(3):322-330. PubMed ID: 29043947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Substance Use Relapse Among Veterans at Termination of Treatment for Substance Use Disorders.
    Betancourt CA; Kitsantas P; Goldberg DG; Hawks BA
    Mil Med; 2022 Oct; 187(11-12):e1422-e1431. PubMed ID: 34272857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inpatient hospitalization for substance use disorders one year after residential rehabilitation: predictors among US veterans.
    Chang G; Martin KB; Tang M; Fleming JA
    Am J Drug Alcohol Abuse; 2016; 42(1):56-62. PubMed ID: 26485005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low levels of initiation, engagement, and retention in substance use disorder treatment including pharmacotherapy among HIV-infected and uninfected veterans.
    Kraemer KL; McGinnis KA; Fiellin DA; Skanderson M; Gordon AJ; Robbins J; Zickmund S; Bryant K; Korthuis PT
    J Subst Abuse Treat; 2019 Aug; 103():23-32. PubMed ID: 31229189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An Analysis of Irregular Discharges From Residential Treatment Programs in the Department of Veterans Affairs Health Care System.
    Riblet NB; Gottlieb DJ; Shiner B; Zubkoff L; Rice K; Watts BV; Rusch B
    Mil Med; 2023 Nov; 188(11-12):e3657-e3666. PubMed ID: 37167031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impulsivity and Medical Care Utilization in Veterans Treated for Substance Use Disorder.
    Bjork JM; Reisweber J; Burchett JR; Plonski PE; Konova AB; Lopez-Guzman S; Dismuke-Greer CE
    Subst Use Misuse; 2021; 56(12):1741-1751. PubMed ID: 34328052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interpersonal styles, peer relationships, and outcomes in residential substance use treatment.
    Harrison AJ; Timko C; Blonigen DM
    J Subst Abuse Treat; 2017 Oct; 81():17-24. PubMed ID: 28847451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High Risk of Substance Use Disorder-Related Outcomes in Veterans Released from Correctional Facilities in Mid to Late Life.
    Barry LC; Steffens DC; Covinsky KE; Conwell Y; Boscardin J; Li Y; Byers AL
    J Gen Intern Med; 2023 Apr; 38(5):1109-1118. PubMed ID: 36781577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dissemination of cognitive behavioral therapy for substance use disorders in the Department of Veterans Affairs Health Care System: Description and evaluation of Veteran outcomes.
    DeMarce JM; Gnys M; Raffa SD; Kumpula M; Karlin BE
    Subst Abus; 2021; 42(2):168-174. PubMed ID: 31644386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment setting and baseline substance use severity interact to predict patients' outcomes.
    Tiet QQ; Ilgen MA; Byrnes HF; Harris AH; Finney JW
    Addiction; 2007 Mar; 102(3):432-40. PubMed ID: 17298651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive validity of a quality measure for intensive substance use disorder treatment.
    Schmidt EM; Gupta S; Bowe T; Ellerbe LS; Phelps TE; Finney JW; Asch SM; Humphreys K; Trafton J; Vanneman M; Harris AHS
    Subst Abus; 2017; 38(3):317-323. PubMed ID: 27435754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Personality change during substance use disorder treatment is associated with improvements in abstinence self-efficacy post-treatment among U.S. military veterans.
    Blonigen DM; Macia KS
    J Subst Abuse Treat; 2021 Jan; 120():108187. PubMed ID: 33298306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.